Use of metabotyping for optimal nutrition

Current Opinion in Biotechnology

Volumn 44, Issue , 2017, Pages 35-38

  Brennan, Lorraine ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY;

METABOLIC PROFILES; METABOLOMICS; NOCV1;

NUTRITION;

DIETARY INTAKE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INDIVIDUALIZATION; INTESTINE FLORA; METABOLOMICS; METABOTYPING; NUTRITION; NUTRITIONAL ASSESSMENT; PERSONALISED NUTRITION; PRIORITY JOURNAL; REVIEW; ANIMAL; DIET; PROCEDURES;

ANIMALS; DIET; HUMANS; METABOLOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 84994651580     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.10.008     Document Type: Review

References (25)

1. 1 Nizel, A.E., Personalized nutrition counseling. ASDC J Dent Child 39 (1972), 353–360.
2. 2 Tierney, A.C., McMonagle, J., Shaw, D.I., Gulseth, H.L., Helal, O., Saris, W.H., Paniagua, J.A., Golabek-Leszczynska, I., Defoort, C., Williams, C.M., Karsltrom, B., et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int J Obes 35 (2011), 800–809.
3. 3 Gibney, M.J., Walsh, M.C., The future direction of personalised nutrition: my diet, my phenotype, my genes. Proc Nutr Soc 72 (2013), 219–225.
4. 4 Celis-Morales, C., Livingstone, K.M., Marsaux, C.F., Forster, H., O'Donovan, C.B., Woolhead, C., Macready, A.L., Fallaize, R., Navas-Carretero, S., San-Cristobal, R., Kolossa, S., et al. Design and baseline characteristics of the Food4me study: a web-based randomised controlled trial of personalised nutrition in seven European countries. Genes Nutr, 10, 2015, 450.
5. 5•• Celis-Morales, C., Livingstone, K.M., Marsaux, C.F., Macready, A.L., Fallaize, R., O'Donovan, C.B., Woolhead, C., Forster, H., Walsh, M.C., Navas-Carretero, S., San-Cristobal, R., et al. Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial. Int J Epidemiol, 2016 A good demonstration of the effect of personalised nutrition on dietary intake: personalisation resulted in improved intakes and an overall healthier diet.
6. 6•• O'Donovan, C.B., Walsh, M.C., Nugent, A.P., McNulty, B., Walton, J., Flynn, A., Gibney, M.J., Gibney, E.R., Brennan, L., Use of metabotyping for the delivery of personalised nutrition. Mol Nutr Food Res 59 (2015), 377–385 A demonstration of the concept of using metabotyping for the delivery of personalised nutrition.
7. 7 Brennan, L., Session 2: personalised nutrition. Metabolomic applications in nutritional research. Proc Nutr Soc 67 (2008), 404–408.
8. 8•• O'Donovan, C.B., Walsh, M.C., Gibney, M.J., Gibney, E.R., Brennan, L., Can metabotyping help deliver the promise of personalised nutrition?. Proc Nutr Soc 75 (2016), 106–114 Good review that is relevant to the topic of metabotyping.
9. 9 Kaddurah-Daouk, R., Weinshilboum, R., Pharmacometabolomics Research Network. Metabolomic signatures for drug response phenotypes: Pharmacometabolomics enables precision medicine. Clin Pharmacol Ther 98 (2015), 71–75.
10. 10 Kaddurah-Daouk, R., Boyle, S.H., Matson, W., Sharma, S., Matson, S., Zhu, H., Bogdanov, M.B., Churchill, E., Krishnan, R.R., Rush, A.J., Pickering, E., et al. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry, 2011, 1.
11. 11• Holmes, E., Wilson, I.D., Nicholson, J.K., Metabolic phenotyping in health and disease. Cell 134 (2008), 714–717 Good overview of the potential of metabolic phenotyping in health and disease.
12. 12 Nyamundanda, G., Brennan, L., Gormley, I.C., Probabilistic principal component analysis for metabolomic data. BMC Bioinform, 11, 2010, 571.
13. 13 Engel, J., Blanchet, L., Engelke, U.F., Wevers, R.A., Buydens, L.M., Towards the disease biomarker in an individual patient using statistical health monitoring. PLOS ONE, 9, 2014, e92452.
14. 14 O'Sullivan, A., Gibney, M.J., Connor, A.O., Mion, B., Kaluskar, S., Cashman, K.D., Flynn, A., Shanahan, F., Brennan, L., Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 55 (2011), 679–690.
15. 15 Morris, C., O'Grada, C., Ryan, M., Roche, H.M., Gibney, M.J., Gibney, E.R., Brennan, L., Identification of differential responses to an oral glucose tolerance test in healthy adults. PLOS ONE, 8, 2013, e72890.
16. 16• van Bochove, K., van Schalkwijk, D.B., Parnell, L.D., Lai, C.Q., Ordovas, J.M., de Graaf, A.A., van Ommen, B., Arnett, D.K., Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy. PLoS ONE, 7, 2012, e38072 Demonstration of use of the concept of metabotyping for identification of response to drug therapy.
17. 17 Yet, I., Menni, C., Shin, S.Y., Mangino, M., Soranzo, N., Adamski, J., Suhre, K., Spector, T.D., Kastenmuller, G., Bell, J.T., Genetic influences on metabolite levels: a comparison across metabolomic platforms. PLOS ONE, 11, 2016, e0153672.
18. 18 Raffler, J., Friedrich, N., Arnold, M., Kacprowski, T., Rueedi, R., Altmaier, E., Bergmann, S., Budde, K., Gieger, C., Homuth, G., Pietzner, M., et al. Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality. PLoS Genetics, 11, 2015, e1005487.
19. 19 Gieger, C., Geistlinger, L., Altmaier, E., Hrabe de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.W., Wichmann, H.E., Weinberger, K.M., Adamski, J., Illig, T., et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet, 4, 2008, e1000282.
20. 20 Illig, T., Gieger, C., Zhai, G., Romisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmuller, G., Kato, B.S., Mewes, H.W., Meitinger, T., et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42 (2010), 137–141.
21. 21 Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., Harris, H.M., Coakley, M., Lakshminarayanan, B., O'Sullivan, O., Fitzgerald, G.F., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
22. 22 Wijeyesekera, A., Clarke, P.A., Bictash, M., Brown, I.J., Fidock, M., Ryckmans, T., Yap, I.K., Chan, Q., Stamler, J., Elliott, P., Holmes, E., et al. Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: intermap study. Anal Methods Adv Methods Appl 4 (2012), 65–72.
23. 23 Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., Host–gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
24. 24 Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., Hoyles, L., et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab 22 (2015), 320–331.
25. 25 Beger, R.D., Dunn, W., Schmidt, M.A., Gross, S.S., Kirwan, J.A., Cascante, M., Brennan, L., Wishart, D.S., Oresic, M., Hankemeier, T., Broadhurst, D.I., et al. Metabolomics enables precision medicine: “a white paper, community perspective”. Metabolomics, 12, 2016, 149.